Skip to main content
Log in

Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia

  • Letter to the Editor
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’Er I, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460: 753–757.

    Article  CAS  Google Scholar 

  2. Luan ZL, Cui XH, Xu H, Lu HY, Li YY, Lu TL, et al. Association of MSI2 gene polymorphism with age-at-onset of schizophrenia in a Chinese population. Neurosci Bull 2017, 33: 731–733.

    Article  CAS  Google Scholar 

  3. Takekita Y, Fabbri C, Kato M, Nonen S, Sakai S, Sunada N, et al. HTR1A gene polymorphisms and 5-HT1A receptor partial agonist antipsychotics efficacy in schizophrenia. J Clin Psychopharmacol 2015, 35: 220–227.

    Article  CAS  Google Scholar 

  4. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004, 23: 540–545.

    Article  CAS  Google Scholar 

  5. Pohjalainen T, Rinne J, Någren K, Lehikoinen P, Anttila K, Syvälahti E, et al. The A1 allele of the human D 2 dopamine receptor gene predicts low D 2 receptor availability in healthy volunteers. Mol Psychiatry 1998, 3: 256–260.

    Article  CAS  Google Scholar 

  6. Zhang JP, Lencz T, Malhotra AK. D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am J Psychiatry 2010, 167: 763–772.

    Article  Google Scholar 

  7. Gamazon ER, Segrè AV, van de Bunt M, Wen X, Xi HS, Hormozdiari F, et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease-and trait-associated variation. Nat Genet 2018, 50: 956–967.

    Article  CAS  Google Scholar 

  8. Need AC, Keefe RS, Ge D, Grossman I, Dickson S, McEvoy JP, et al. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Eur J Hum Genet 2009, 17: 946–957.

    Article  CAS  Google Scholar 

  9. Ji X, Takahashi N, Saito S, Ishihara R, Maeno N, Inada T, et al. Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population. Neurosci Lett 2008, 435: 95–98.

    Article  CAS  Google Scholar 

  10. Mcmahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006, 78: 804–814.

    Article  CAS  Google Scholar 

  11. Lin JY, Jiang MY, Kan ZM, Chu Y. Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis. J Affect Disord 2014, 168: 430–438.

    Article  CAS  Google Scholar 

  12. Staeker J, Leucht S, Laika B, Steimer W. Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients. Genet Test Mol Biomarkers 2014, 18: 20–31.

    Article  CAS  Google Scholar 

  13. Laika B, Leucht S, Heres S, Schneider H, Steimer W. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Pharmacogenomics J 2010, 10: 20–29.

    Article  CAS  Google Scholar 

  14. Noro M, Antonijevic I, Forray C, Kasper S, Kocabas NA, Lecrubier Y, et al. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. Int Clin Psychopharmacol 2010, 25: 228–231.

    Article  Google Scholar 

  15. Pitychoutis PM, Belmer A, Moutkine I, Adrien J, Maroteaux LJN. Mice lacking the serotonin Htr 2B receptor gene present an antipsychotic-sensitive schizophrenic-like phenotype. Neuropsychopharmacology 2015, 40: 2764–2773.

    Article  CAS  Google Scholar 

  16. Selvaraj S, Arnone D, Cappai A, Howes OJN, Reviews B. Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies. Neurosci Biobehav Rev 2014, 45: 233–245.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Basic Research Development Program (2016YFC0904300), the National Natural Science Foundation of China (81630030 and 81461168029), and the 1.3.5 Project for Disciplines of Excellence of West China Hospital, Sichuan University (ZY2016103 and ZY2016203), China.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding authors

Correspondence to Chao Chen or Tao Li.

Ethics declarations

Conflict of interest

All authors claim that there are no conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 182 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, L., Wang, H., Zhang, Y. et al. Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia. Neurosci. Bull. 35, 1102–1105 (2019). https://doi.org/10.1007/s12264-019-00432-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-019-00432-2

Navigation